HUMAN-IMMUNODEFICIENCY-VIRUS INDUCTION OF MALIGNANT TRANSFORMATION IN HUMAN LYMPHOCYTES-B

被引:88
作者
LAURENCE, J [1 ]
ASTRIN, SM [1 ]
机构
[1] FOX CHASE CANC INST,INST CANC RES,PHILADELPHIA,PA 19111
关键词
C-MYC; EPSTEIN-BARR VIRUS; B-CELL LYMPHOMA; TRANSACTIVATION;
D O I
10.1073/pnas.88.17.7635
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aggressive B-cell lymphomas are occurring with increasing incidence among individuals infected with human immunodeficiency virus (HIV). Several lines of evidence implicate both Epstein-Barr virus (EBV) and c-myc activation in the pathogenesis of a major subset of these tumors. These observations prompted our investigation of interactions among EBV, c-myc, and HIV in primary B cells. We show that nonimmortalized peripheral B lymphocytes from EBV-seropositive, HIV-seronegative donors can be infected by HIV and that a subset of these lymphocytes become transformed. Malignant transformation was documented by several criteria. These cells displayed altered growth properties, propagating in 1% serum and cloning in soft agar, and formed invasive tumors of Burkitt lymphoma phenotype after subcutaneous injection into severe combined immunodeficiency mice. Such cells revealed marked enhancement of EBV DNA and RNA and of endogenous c-myc transcripts and protein. HIV-1 infection of already immortalized B-cell lines led to a similar upregulation of EBV and c-myc transcripts. These data indicate that HIV has properties of a transforming retrovirus, as it mediates two events linked to B-cell neoplasia: deregulation of c-myc and activation of EBV. They also raise the possibility of a role for HIV, apart from induction of immune suppression, in the pathogenesis of B-cell lymphoma in the acquired immune deficiency syndrome.
引用
收藏
页码:7635 / 7639
页数:5
相关论文
共 49 条
[1]  
BECKHARDT RN, 1988, MT SINAI J MED, V55, P383
[2]  
BRESSER J, 1984, P NATL ACAD SCI USA, V80, P6523
[3]   EPSTEIN-BARR-VIRUS INDUCES AGGRESSIVE LYMPHOPROLIFERATIVE DISORDERS OF HUMAN B-CELL ORIGIN IN SCID/HU CHIMERIC MICE [J].
CANNON, MJ ;
PISA, P ;
FOX, RI ;
COOPER, NR .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) :1333-1337
[4]   LOCALIZATION OF B-CELL STIMULATORY ACTIVITY OF HIV-1 TO THE CARBOXYL TERMINUS OF GP41 [J].
CHIRMULE, N ;
KALYANARAMAN, VS ;
SAXINGER, C ;
WONGSTAAL, F ;
GHRAYEB, J ;
PAHWA, S .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (03) :299-305
[5]   ROLE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND OTHER VIRUSES IN MALIGNANCIES ASSOCIATED WITH ACQUIRED IMMUNODEFICIENCY DISEASE SYNDROME [J].
CREMER, KJ ;
SPRING, SB ;
GRUBER, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (12) :1016-1024
[6]   DIFFERENCES AMONG HUMAN IMMUNODEFICIENCY VIRUS-STRAINS IN THEIR CAPACITIES TO INDUCE CYTOLYSIS OR PERSISTENT INFECTION OF A LYMPHOBLASTOID CELL-LINE IMMORTALIZED BY EPSTEIN-BARR-VIRUS [J].
DAHL, K ;
MARTIN, K ;
MILLER, G .
JOURNAL OF VIROLOGY, 1987, 61 (05) :1602-1608
[7]   INFECTION OF EPSTEIN-BARR VIRUS-TRANSFORMED LYMPHOBLASTOID B-CELLS BY THE HUMAN-IMMUNODEFICIENCY-VIRUS - EVIDENCE FOR A PERSISTENT AND PRODUCTIVE INFECTION LEADING TO B-CELL PHENOTYPIC CHANGES [J].
DEROSSI, A ;
RONCELLA, S ;
CALABRO, ML ;
DANDREA, E ;
PASTI, M ;
PANOZZO, M ;
MAMMANO, F ;
FERRARINI, M ;
CHIECOBIANCHI, L .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (09) :2041-2049
[8]  
FORD RJ, 1990, AIDS RES HUM RETROV, V6, P142
[9]   ACTIVITY OF SYNTHETIC PEPTIDES FROM THE TAT PROTEIN OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
FRANKEL, AD ;
BIANCALANA, S ;
HUDSON, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (19) :7397-7401
[10]   DISSEMINATED OR LOCALIZED GROWTH OF A HUMAN B-CELL TUMOR (DAUDI) IN SCID MICE [J].
GHETIE, MA ;
RICHARDSON, J ;
TUCKER, T ;
JONES, D ;
UHR, JW ;
VITETTA, ES .
INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (03) :481-485